Understanding vision mechanisms to develop treatments for retinal diseases in veterans
Official title: BLRD Research Career Scientist Award Application
Funded at Veterans Health Administration · NIH-11052959 · Data updated 2026-11-12
This study is exploring how our eyes work and what goes wrong in certain eye diseases, especially for veterans, to find new ways to help improve or restore vision for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Long Beach, United States) |
| Project start | October 1, 2024 |
| Project end | September 30, 2029 |
| Funding year | 2025 |
| NIH project number | 1IK6BX006800-01 |
| Project ID | NIH-11052959 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans experiencing retinal diseases, particularly age-related macular degeneration and other related conditions.
✕Less likely to help
Patients with retinal diseases unrelated to the mechanisms being studied or those who do not meet the veteran status may not benefit from this research.
What this research studies
This research focuses on uncovering the biological processes that enable vision and how these processes are affected in retinal diseases, particularly those impacting veterans. The Kiser laboratory employs various experimental techniques, including atomic-level studies of proteins involved in vision and the creation of animal models to simulate retinal diseases. By investigating the visual cycle and its modulation, the research aims to identify potential therapeutic strategies to improve or restore vision in affected individuals. The ultimate goal is to develop effective treatments for retinal diseases that currently have limited options.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve vision and quality of life for veterans suffering from retinal diseases.
How similar studies have gone: Previous research in visual cycle modulation has shown promise in developing therapies for retinal diseases, indicating that this approach has potential for success.
Where this research is happening
-
Veterans Health Administration
Long Beach, United States Active
Researchers
- Principal investigator: Kiser, Philip David — Veterans Health Administration
- Study coordinator: Kiser, Philip David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.